Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01999478 · ClinicalTrials.gov registry record
Novel Biophotonics Methodology for Colon Cancer Screening
A clinical trial, sponsored by Boston Medical Center.
- Completed
- Registry status
- 4,000
- Enrollment target
NCT01999478: Completed study, sponsored by Boston Medical Center.
NCT01999478 is a clinical trial that has completed, run by Boston Medical Center. The registered enrollment target is 4,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01999478 has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- 4,000 participants
- Enrollment target
Study Summary
The study is testing a new, safe and effective way for the early detection of colon cancer. The method uses Low-coherence Enhanced Backscattering Spectroscopy (LEBS). This is an optic probe which is a small device that uses light (not laser) to assess the colon lining. This probe will be used before colonoscopy to identify subjects who do and do not have precancerous changes in the colon by capturing the light reflected back from the rectal wall and that will be assessed without the need for colonoscopy and bowel preparation (colon cleaning). This device may detect early cancerous changes in colon tissue with higher accuracy than current tests.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2008-02 |
| Est. Completion | 2015-02 |
What the finished NCT01999478 record still lists
NCT01999478 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01999478 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01999478 about?
NCT01999478 is a clinical study titled "Novel Biophotonics Methodology for Colon Cancer Screening". The study is testing a new, safe and effective way for the early detection of colon cancer. The method uses Low-coherence Enhanced Backscattering Spectroscopy (LEBS). This is an optic probe which is a small device that uses light (not laser) to assess the colon lining. This probe will be used before...
What is the current status of trial NCT01999478?
This trial is currently completed. The enrollment target is 4,000 participants. The study started on 2008-02. Estimated completion is 2015-02.
Who is sponsoring clinical trial NCT01999478?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia